(Q40971918)

English

Implantable defibrillators are preferable to pharmacologic therapy for patients with ventricular tachyarrhythmias: an antagonist's viewpoint

scientific article published on March 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1 reference

Europe PubMed Central

Implantable defibrillators are preferable to pharmacologic therapy for patients with ventricular tachyarrhythmias: an antagonist's viewpoint (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1 reference

based on heuristic

inferred from title

author name string

Anderson J

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

publication date

1 March 1996

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Progress in Cardiovascular Diseases

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

393-400

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome with the automatic implantable cardioverter-defibrillator.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival after implantation of the cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of defibrillator therapy and other therapeutic modalities for sustained ventricular tachycardia or ventricular fibrillation associated with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. The ESVEM Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of sotalol for one year after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Cardiac Arrest in Seattle, Conventional versus Amiodarone Drug Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The paradox of beta-adrenergic blockade for the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2896%2980033-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0033-0620(96)80033-8

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

release_pb6jsktz7bc4jdav7us5shkhma

1 reference

https://api.fatcat.wiki/v0/release/pb6jsktz7bc4jdav7us5shkhma

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40971918&oldid=1911315616"